AGM/EGMJun 16, 2026, 04:17 PM
MiMedx Group Shareholders Re-elect Directors, Approve Comp & Auditor
AI Summary
MiMedx Group, Inc. held its 2026 Annual Meeting of Shareholders on June 10, 2026, where shareholders re-elected seven directors, approved an advisory resolution on executive compensation, and ratified Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026. Additionally, the Board of Directors approved an amendment to the company's bylaws, increasing the number of public company boards its chief executive officer may sit on to three.
Key Highlights
- MiMedx Group's Board approved an amendment to bylaws on June 10, 2026.
- The amendment increased the CEO's permissible public company board seats to three.
- The 2026 Annual Meeting of Shareholders was held on June 10, 2026.
- Approximately 84.2% (125,360,965 shares) of votes were represented at the meeting.
- Shareholders re-elected seven directors to the Board.
- An advisory resolution regarding executive compensation was approved with 95,158,451 votes for.
- Deloitte & Touche LLP was ratified as the independent auditor for 2026 with 123,687,080 votes for.
Price Impact
More from MDXG